Norges Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Norges Bank’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,815,111	Closed	-$85.3M	–	1376
2025 Q2	$85.3M	Buy	1,815,111 +981,611	+118%	+$43.7M	0.01%	763
2025 Q1	$36.8M	Buy	833,500 +646,997	+347%	+$29.8M	0.01%	1056
2024 Q4	$6.74M	Sell	186,503 -46,845	-20%	-$1.64M	﹤0.01%	1431
2024 Q3	$7.48M	Sell	233,348 -46,995	-17%	-$1.76M	﹤0.01%	1428
2024 Q2	$10.6M	Sell	280,343 -77,093	-22%	-$3.24M	﹤0.01%	1383
2024 Q1	$17.6M	Buy	357,436 +19,603	+6%	+$906K	﹤0.01%	1305
2023 Q4	$12.3M	Buy	337,833 +70,000	+26%	+$1.83M	﹤0.01%	1419
2023 Q3	$6.19M	Hold	267,833	–	–	﹤0.01%	1632
2023 Q2	$7.02M	Hold	267,833	–	–	﹤0.01%	1630
2023 Q1	$6.89M	Sell	267,833 -89,861	-25%	-$2.63M	﹤0.01%	1681
2022 Q4	$9.3M	Hold	357,694	–	–	﹤0.01%	1595
2022 Q3	$10.2M	Sell	357,694 -154,199	-30%	-$4.42M	﹤0.01%	1533
2022 Q2	$12.6M	Sell	511,893 -436,472	-46%	-$16M	﹤0.01%	1451
2022 Q1	$53.5M	Buy	948,365 +374,584	+65%	+$21.4M	0.01%	844
2021 Q4	$35.6M	Buy	573,781 +77,438	+16%	+$5.12M	0.01%	1126
2021 Q3	$31.5M	Sell	496,343 -32,623	-6%	-$2.51M	0.01%	1177
2021 Q2	$43.6M	Buy	528,966 +92,631	+21%	+$7.03M	0.01%	1051
2021 Q1	$32.1M	Sell	436,335 -34,657	-7%	-$2.71M	0.01%	1253
2020 Q4	$34.2M	Buy	470,992 +221,980	+89%	+$14.3M	0.01%	1229
2020 Q3	$11.9M	Buy	249,012 +24,812	+11%	+$1.06M	﹤0.01%	1659
2020 Q2	$9.42M	Buy	224,200 +24,200	+12%	+$861K	﹤0.01%	1728
2020 Q1	$5.4M	Hold	200,000	–	–	﹤0.01%	1810
2019 Q4	$7.7M	Hold	200,000	–	–	﹤0.01%	1850
2019 Q3	$4.34M	Buy	+200,000	New	+$4.73M	﹤0.01%	1927

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Norges Bank's SWTX Position: Q3 2025 in Review

Norges Bank sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,815,111 shares — an estimated $85.3M sold.

Norges Bank first reported a position in SWTX in Q3 2019 and held it in 24 quarters. The position peaked at $85.3M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Norges Bank reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Norges Bank sold 1,815,111 SpringWorks Therapeutics shares in Q3 2025, an estimated $85.3M.
Norges Bank first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 24 quarters.
Norges Bank's SpringWorks Therapeutics position peaked at $85.3M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.